Literature DB >> 2222018

Surgical therapy in Barrett's esophagus.

T R DeMeester1, S E Attwood, T C Smyrk, D H Therkildsen, R A Hinder.   

Abstract

Seventy-six patients with Barrett's esophagus were cared for during a 10-year period. Fifty-six patients (74%) presented with complications of the disease. There were 20 strictures, 7 giant ulcers, 11 cases of dysplasia, and 29 patients with carcinoma. In patients with benign disease, 93% had mechanically defective sphincters and 83% had peristaltic failure of the lower esophageal body. Esophageal pH monitoring showed excessive esophageal exposure to pH less than 4 in 93% and excessive exposure to pH more than 7 in 34% of the patients tested. Ninety-three per cent of patients with excessive alkaline exposure had complications, compared to only 44% with normal alkaline exposure (p less than 0.01). Gastric pH monitoring, serum gastrin levels, and gastric acid analysis supported a duodenal source for the alkaline exposure. Antireflux surgery was performed using Nissen fundoplication in 30, Belsey partial fundoplication in 3, and Collis-Belsey gastroplasty in 2. Six required resection with colon interposition. Good symptomatic control was achieved in 77% after antireflux surgery. Four patients had symptoms and signs of duodenogastric reflux; three required a bile diversion procedure. Fifteen patients had an en bloc curative resection with colon interposition. One patient with high-grade dysplasia on biopsy was found to have intramucosal carcinoma after simple esophagectomy. Five tumors were intramucosal, seven were intramural, and four were transmural. Lymph node involvement occurred only in the latter two. Actuarial survival 5 years after curative resection was 53%. Median survival time for patients after palliative resection or no resection was 12 months. Study of en bloc specimens indicated that extent of resection should be adapted to extent of disease: esophagectomy for intramucosal disease, en bloc esophagectomy with splenic preservation for intramural and transmural disease. Serum CEA was useful in detecting recurrent disease after surgery when the primary tumor stained positively for CEA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222018      PMCID: PMC1358292          DOI: 10.1097/00000658-199010000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  The lower esophageal sphincter in health and disease.

Authors:  G Zaninotto; T R DeMeester; W Schwizer; K E Johansson; S C Cheng
Journal:  Am J Surg       Date:  1988-01       Impact factor: 2.565

2.  Selective therapeutic approach to cancer of the lower esophagus and cardia.

Authors:  T R DeMeester; G Zaninotto; K E Johansson
Journal:  J Thorac Cardiovasc Surg       Date:  1988-01       Impact factor: 5.209

3.  Composite gastric carcinoma. Report of a tumor of the carcinoma-carcinoid spectrum.

Authors:  T R Ulich; M Kollin; K J Lewin
Journal:  Arch Pathol Lab Med       Date:  1988-01       Impact factor: 5.534

4.  Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.

Authors:  B J Reid; W M Weinstein; K J Lewin; R C Haggitt; G VanDeventer; L DenBesten; C E Rubin
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

5.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

6.  Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus.

Authors:  M B Orringer
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

7.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus.

Authors:  C S Robertson; J F Mayberry; D A Nicholson; P D James; M Atkinson
Journal:  Br J Surg       Date:  1988-08       Impact factor: 6.939

8.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Authors:  A P Naef; M Savary; L Ozzello
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

9.  Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy.

Authors:  C Iascone; T R DeMeester; A G Little; D B Skinner
Journal:  Arch Surg       Date:  1983-05

10.  Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients.

Authors:  T R DeMeester; L Bonavina; M Albertucci
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

View more
  43 in total

1.  Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.

Authors:  J W van Sandick; J J van Lanschot; B W Kuiken; G N Tytgat; G J Offerhaus; H Obertop
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

2.  [Laparoscopic fundoplication. Indications and results].

Authors:  K H Fuchs; H Feussner
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

3.  Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn; Juan Carlos Díaz; Jorge Rojas
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

4.  What is the place of antrectomy with Roux-en-Y in the treatment of reflux disease? Experience with 83 total duodenal diversions.

Authors:  F Fekete; D Pateron
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 5.  Pathogenesis of columnar-lined esophagus.

Authors:  Kamal E Bani-Hani; Bayan K Bani-Hani
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

6.  Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis.

Authors:  Dan Comay; Gord Blackhouse; Ron Goeree; David Armstrong; John K Marshall
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

7.  Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: the need for long-term subjective and objective follow-up.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Gladys Smok; Cesar Castro; Owen Korn; Ana Henríquez
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

Review 8.  How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus.

Authors:  Philippe G Guillem
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 9.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

10.  The impact of an antireflux procedure on intestinal metaplasia of the cardia.

Authors:  S R DeMeester; G M Campos; T R DeMeester; C G Bremner; J A Hagen; J H Peters; P F Crookes
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.